Product news

Share this article:
Novo Nordisk AS and Sciele Pharma Inc. announced on Wednesday the launch of a type 2 diabetes combination drug. PrandiMet combines Novo Nordisk's Prandin (repaglinide) with the generic drug metformin.
Share this article:

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

AstraZeneca takes on pediatricians

The American Academy of Pediatricians says an AstraZeneca drug for preemies should be used less often, and the drugmaker is fighting back with an ad campaign that says the new guidelines put too many at risk.

UK generic use soared in 2013

Generics made up almost 75% of prescriptions in the United Kingdom last year.

GSK refutes consumer spin-off rumor

The company refutes a Financial Times rumor that one was happening soonish.